HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice.

AbstractOBJECTIVE:
Emerging evidence suggests female type 2 diabetes (T2DM) patients may fare worse than males with respect to cardiovascular complications. Hence the impact of sex on relative progression of left ventricular (LV) remodeling in obese db/db mice was characterized.
METHODS:
The changes in parameters of LV hypertrophy (heart weight, pro-hypertrophic gene expression, cardiomyocyte size) and fibrosis (LV collagen deposition and oxidative stress), in parallel with body weight and blood glucose and lipid profiles, in male and female db/db T2DM mice, at 10, 14, and 18 weeks of age, were determined.
RESULTS:
Diabesity-induced cardiac remodeling was at least comparable in female (compared to male) mice. Females exhibited enhanced systemic oxidative stress and nonesterified fatty acid levels. Progression of LV pro-hypertrophic (β-myosin heavy chain, B-type natriuretic peptide) and pro-oxidant gene expression (NADPH oxidase subunit Nox2, plasminogen activator inhibitor-1 PAI-I) was, however, exaggerated in females when expressed relative to 10-week-old db/db mice. Increased cardiomyocyte width was also evident earlier in db/db females than males. No other gender differences were observed.
CONCLUSIONS:
Progressive, age-dependent development of cardiac remodeling in db/db mice parallels impairments in glucose handling and oxidative stress. Certain aspects of the T2DM-induced LV remodeling response may have an earlier and/or exaggerated onset in diabetic females.
AuthorsMarissa A Bowden, Greg H Tesch, Tracey L Julius, Sarah Rosli, Jane E Love, Rebecca H Ritchie
JournalObesity (Silver Spring, Md.) (Obesity (Silver Spring)) Vol. 23 Issue 6 Pg. 1166-77 (Jun 2015) ISSN: 1930-739X [Electronic] United States
PMID25959739 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Obesity Society.
Chemical References
  • Blood Glucose
  • Plasminogen Activator Inhibitor 1
  • Reactive Oxygen Species
  • SERPINE1 protein, human
  • Natriuretic Peptide, Brain
Topics
  • Animals
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 2 (complications)
  • Female
  • Fibrosis
  • Heart (physiopathology)
  • Hypertrophy, Left Ventricular (physiopathology)
  • Male
  • Mice
  • Mice, Obese (metabolism)
  • Models, Animal
  • Myocytes, Cardiac (metabolism)
  • Natriuretic Peptide, Brain
  • Oxidative Stress (physiology)
  • Plasminogen Activator Inhibitor 1
  • Reactive Oxygen Species (metabolism)
  • Sex Factors
  • Ventricular Remodeling (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: